Splenectomy Protects against Sepsis Lethality and Reduces Serum HMGB1 Levels-Reference-Cited by-同舟云学术

Splenectomy Protects against Sepsis Lethality and Reduces Serum HMGB1 Levels

Published:2008-08-19 Issue:5 Volume:181 Page:3535-3539
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Huston Jared M.,Wang Haichao,Ochani Mahendar,Ochani Kanta,Rosas-Ballina Mauricio,Gallowitsch-Puerta Margot,Ashok Mala,Yang Lihong,Tracey Kevin J.,Yang Huan

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. HMG-1 as a Late Mediator of Endotoxin Lethality in Mice

3. Reversing established sepsis with antagonists of endogenous high-mobility group box 1

4. The cytokine activity of HMGB1

5. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora/subdiaphragmatic vagus nerve/spleen axis;International Immunopharmacology;2024-01

2. Adenosine 2A receptor antagonists promote lymphocyte proliferation in sepsis by inhibiting Treg expression of PD‐L1 in spleen;Immunology;2023-12-30

3. Esketamine prevents cognitive deficiency via intestinal flora/subdiaphragmatic vagus nerve/spleen axis after a secondary LPS exposure;2023-08-28

4. Toll-like receptor 2 deficiency relieves splenic immunosuppression during sepsis;Immunobiology;2023-05

5. Splenectomy for treating hepatosplenic candidiasis: Two cases and literature review suggesting its feasibility;Heliyon;2023-04